Former Clemson Point Guard Diagnosed with 'Serious Neurological Condition'

Former Clemson PG Rod Hall is facing a serious health battle after a medical emergency during an alumni game, and his family ...
Virginia Connection Newspapers

Reston Hospital Center Launches Neuro Intervention Program

Reston Hospital Center announced its launch of the next phase of its established stroke program, through a partnership with the nationally-regarded neurovascular surgery team from MedStar Washington ...

Local students making film about youth romance, featuring star lead actor

Envision Cinema Conservatory program and other local San Diegan artists are collaborating this summer on a short rom-com film ...

Dr. Susha Thomas Expands Parkinson’s Learning Resources Through ParkinsonsTips.com and Her Books

ParkinsonsTips.com, an educational platform founded by Dr. Susha Thomas, PT, DPT, C/NDT, continues to provide individuals living with Parkinson’s disease, caregivers, and healthcare professionals with ...
Las Vegas Sun

Niagen Bioscience Launches Pharmaceutical Program for Accelerated Aging and Rare Genetic Diseases

Niagen Bioscience, Inc. (NASDAQ: NAGE), the global authority on NAD+ science, today announced the formal launch of the first drug candidate of NAD Pharmaceuticals Corp., its wholly owned subsidiary ...

Former Tennessee Titans safety Myron Rolle joins NFLPA in medical advisory role

Former Tennessee Titan safety Myron Rolle will use his expertise as a neurosurgeon in joining the NFLPA in an advisory role.
The Manila Times

Dysport® is the first botulinum toxin to achieve positive topline Phase III results in both episodic and chronic migraine.

Dysport® achieved statistically significant topline Phase III results, meeting primary endpoints in both episodic (E-BEOND) and chronic (C-BEOND) migraineDysport is the first botulinum toxin in ...
list25 on MSN

25 weird facts about right-handed people you never knew

Explore 25 weird facts about right handed people, from allergy risks to stroke recovery. Discover surprising biological ...
The Manila Times

Alamar Biosciences Launches the First Multiplexed Blood-based Immunoassay for eMTBR-Tau, One of the Most Important Biomarkers in Alzheimer’s Disease Research

MTBR-Tau offers a non-invasive, blood-based measurement of the tau tangle burden, the core pathology associated with disease progression and cognitive decline in Alzheimer’s disease | Immunoassay for ...

Kenai Therapeutics Announces Completion of Enrollment in Phase 1b/2a REPLACE™ Trial of RNDP-001 in Idiopathic Parkinson's Disease

Kenai Therapeutics, a clinical-stage biotechnology company pioneering next generation approaches to cure neurological conditions, today announced the completion of enrollment for the REPLACE™ Phase 1b ...

Argent BioPharma executes CannEpil global licensing deal

Argent to retain ownership of existing and future CannEpil IP and receive 15% royalty on Splash Beverage global CannEpil ...

Alamar Biosciences, Inc.: Alamar Biosciences Launches the First Multiplexed Blood-based Immunoassay for eMTBR-Tau, One of the Most Important Biomarkers in Alzheimer's Disease ...

MTBR-Tau offers a non-invasive, blood-based measurement of the tau tangle burden, the core pathology associated with disease progression and cognitive decline in Alzheimer's disease Immunoassay for ...